An immunomodulatory peptide derived from the thymus gland, approved in several countries for hepatitis B/C and studied for immune enhancement in cancer and infectious diseases.
Scientific reports|2018|Wang F et al.
Thymosin alpha 1 (Tα1) is a biological response modifier that has been introduced into markets for treating several diseases. Given the short serum half-life of Tα1 and the rapid development of Fc fusion proteins, we used genetic engineering method t…
Animal Study
PMID: 30120362
Toxicology in vitro : an international journal published in association with BIBRA|2018|Navolotskaya E et al.
We have preparedI-labeled cholera toxin B subunit (I-labeled CT-B, a specific activity of 98Ci/mmol) and found that it binds to rat IEC-6 and human Caco-2 intestinal epithelial cells with high affinity (K3.6 and 3.7nM, respectively). The binding of l…
Animal Study
PMID: 29262310
Oncology letters|2018|Zhou L et al.
Although liver transplantation (LT) lengthens the survival time of patients with hepatocellular carcinoma (HCC), LT patients exhibit a high recurrence rate; particularly those that had advanced HCC associated with the tumor biological characteristics…
PMID: 30214575
Oncoimmunology|2018|Du D et al.
This study investigated the anti-tumor effects of stereotactic body radiation therapy (SBRT) with thymosin alpha-1 (Tα1) in heavily pretreated, metastatic esophageal squamous cell carcinoma (mESCC) patients. Thirty-one patients with at least 2 metast…
PMID: 30221039
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie|2018|Shen X et al.
Thymosin alpha1 (Tα1) is a multifunctional polypeptide involved in immunoregulation, which universally exists in various organs. The clinical application, however, is limited because of its short half-life. The Fc domain of human IgG has functional p…
Animal Study
PMID: 30243095
Journal of critical care|2017|Liu D et al.
PURPOSE: To assess the effects of urinary trypsin inhibitor (UTI) ulinastatin combined with thymosin alpha1 (Tα1) on sepsis. MATERIALS AND METHODS: The meta-analysis included 8 randomized controlled trials (N=1112 patients) on UTI-based therapy for s…
PMID: 28283220
Transplantation proceedings|2017|Hsu H et al.
BACKGROUND: With the goal of in vivo cultivation of human hepatocytes that have not been sufficient in full differentiation in vitro, the advantage of neonatal thymectomy was verified on expansion of xenogeneic human hepatocyte in the micro-miniature…
PMID: 28104124
Future microbiology|2017|Matteucci C et al.
In spite of the consistent benefits for HIV-1 infected patients undergoing antiretroviral therapy, a complete immune reconstitution is usually not achieved. Actually, antiretroviral therapy may be frequently accompanied by immunological unresponsiven…
ReviewAnimal StudyIn Vitro
PMID: 28106477
The Journal of chemical physics|2017|Kosztołowicz T
Subdiffusion with reaction A+B→B is considered in a system which consists of two homogeneous media joined together; the A particles are mobile, whereas B are static. Subdiffusion and reaction parameters, which are assumed to be independent of time an…
PMID: 28249429
Nature medicine|2017|Romani L et al.
Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) that compromise its chloride channel activity. The most common mutation, p.Phe508del, results in the production of a misfo…
Animal Study
PMID: 28394330
Medicine|2017|He C et al.
There is limited information available concerning the effect of thymalfasin (Tα1) as an adjuvant therapy in hepatocellular carcinoma (HCC) patient who received liver resection. The present study aimed to evaluate whether Tα1 can improve the prognosis…
Observational
PMID: 28422855
Oncotarget|2017|Chen J et al.
Thymosin alpha 1 (Tα1) is an important immunomodulating agent with various clinical applications. The natural form of Tα1 is-acetylated, which was supposed to be related tostability of the hormone. In this study, fusion protein Tα1-HSA was constructe…
PMID: 29221124
Nature medicine|2017|Cantin A, Hanrahan J
PMID: 28475572
Zhonghua yi xue za zhi|2017|Fang S et al.
To investigate the effect of transcatheter arterial chemoembolization(TACE)combined with thymosin alpha1(Tα1)on the autophagy of immune cells from advanced hepatocellular carcinoma.A total of 30 patients with advanced liver cancer enrolled in Lishui…
Clinical Trial
PMID: 28693071
International immunopharmacology|2017|Navolotskaya E et al.
We have preparedI-labeled cholera toxin B subunit (I-labeled CT-B, a specific activity of 98Ci/mmol) and found that its binding to T and B lymphocytes from the blood of healthy donors was high-affinity (K2.8 and 3.0nM, respectively). The binding of l…
PMID: 28719851
Neuroscience bulletin|2017|Wang G et al.
In early life, the immune system plays an essential role in brain development. In our study, the immunopotentiator thymosin alpha-1 (Ta1) was peripherally administered to neonatal mice to explore whether the peripheral immunopotentiator affects neuro…
Animal Study
PMID: 28780644
Stem cells international|2017|Hwang D et al.
Although transdifferentiation of mesenchymal stem cells (MSCs) into neurons increases the possibility of therapeutic use of MSCs for neurodevelopmental disorders, the use of MSCs has the limitation on differentiation efficiency to neuronal lineage an…
In Vitro
PMID: 28808446
Journal of critical care|2017|Liu D et al.
PURPOSE: To assess the effects of urinary trypsin inhibitor (UTI) ulinastatin combined with thymosin alpha1 (Tα1) on sepsis. MATERIALS AND METHODS: The meta-analysis included 8 randomized controlled trials (N=1112 patients) on UTI-based therapy for s…
ReviewMeta-Analysis
PMID: 28069319
Biochemistry. Biokhimiia|2017|Navolotskaya E et al.
In this work,I-labeled cholera toxin B-subunit (CT-B) (specific activity 98 Ci/mmol) was prepared, and its high-affinity binding to human blood T-lymphocytes (K = 3.3 nM) was determined. The binding of theI-labeled CT-B was inhibited by unlabeled int…
PMID: 28988532
Molecules (Basel, Switzerland)|2017|Mandaliti W et al.
Thymosin α1 (Tα1), is a peptidic hormone, whose immune regulatory properties have been demonstrated both in vitro and in vivo and approved in different countries for treatment of several viral infections and cancers. Tα1 assumes a conformation in neg…
Animal StudyIn Vitro
PMID: 29077041